Who owns the SPECTROFAP trademark?

The SPECTROFAP trademark is owned by 3B Pharmaceuticals GmbH.

What class is the SPECTROFAP trademark registered in?

The SPECTROFAP trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for SPECTROFAP?

The USPTO serial number for SPECTROFAP is 79405082.

What is the registration number for SPECTROFAP?

SPECTROFAP is registered under USPTO registration number 0.

Sealvo

Home Search: SPECTROFAPSPECTROFAP #79405082

Back

Updated Oct 17, 2026·37 searches this week

View on USPTO TSDR Find similar marks

SPE

USPTO Trademark Record

PENDING

SPECTROFAP

SN 79405082·Reg 0·Filed Aug 09, 2024

Owner 3B Pharmaceuticals GmbH

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

SPECTROFAP (Serial No. 79405082), Registration No. 0, is a pending US trademark filed on Aug 09, 2024 by 3B Pharmaceuticals GmbH. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Office Action response: November 14, 202628 days remaining

Mark Intelligence

SPECTROFAP (Reg. #0) is a pending US trademark that was filed in 2024 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Aug 09, 2024

SERIAL

79405082

REG#

Filing Information

StatusPENDING

Filing DateAug 09, 2024

Serial Number79405082

Registration No.0

Status DateMay 14, 2026

Mark TypeStandard characters

Attorney DocketTM8340US00

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

23 events

NON-FINAL ACTION WRITTEN

May 14, 2026

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 14, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 14, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 17, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 17, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 17, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Mar 12, 2026

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Feb 25, 2026

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Feb 25, 2026

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

REFUSAL PROCESSED BY IB

Nov 15, 2025

REFUSAL PROCESSED BY IB

NON-FINAL ACTION WRITTEN

Oct 20, 2025

NON-FINAL ACTION WRITTEN

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 31, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 31, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 31, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Apr 19, 2025

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Mar 31, 2025

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Mar 31, 2025

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Feb 25, 2025

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Feb 24, 2025

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Feb 18, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 01, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Oct 01, 2024

APPLICATION FILING RECEIPT MAILED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Sep 26, 2024

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by 3B Pharmaceuticals GmbH

Additional USPTO filings from the same owner.

BP3

BP 3B PHARMACEUTICALS

79231543

3B Pharmaceuticals GmbH

REGISTERED

ESC

ESCALATE

87489535

3B Pharmaceuticals GmbH

REGISTERED

Other Marks by Gabrielle A. Holley

Additional USPTO filings handled by the same attorney of record.

STO

STORMLIGHT

79431991

REGISTERED

FIR

FIRST PRIORITY

99518015

REGISTERED

SHA

SHADOWSPEC

79270820

REGISTERED

MYA

MYAIR

79189930

REGISTERED

SPECTROFAP

Run a conflict check

Other Marks by 3B Pharmaceuticals GmbH

Other Marks by Gabrielle A. Holley

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company